Advances in Cancer Research

Advances in Cancer Research, 1st Edition

Advances in Cancer Research, 1st Edition,George Vande Woude,George Klein,ISBN9780120066957

Advances in Cancer Research

Vande Woude   &   Klein   

Academic Press




229 X 152

Print Book + eBook

USD 225.00
USD 375.00

Buy both together and save 40%

Print Book


In Stock

Estimated Delivery Time
USD 190.00

eBook Overview

VST (VitalSource Bookshelf) format

DRM-free included formats : PDF

USD 185.00
Add to Cart


The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.


Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.

George Vande Woude

Affiliations and Expertise

Director, Van Andel Research Institute, Grand Rapids, MI, USA

View additional works by George F. Vande Woude

George Klein

Affiliations and Expertise

Karolinska Insitutet, Stockholm, Sweden

View additional works by George Klein

Advances in Cancer Research, 1st Edition

NY-ESO-1: Review of an Immunogenic Tumor Antigen.
Order, Disorder, Death: Lessons from a Superorganism.
Control of Differentiation in Progression of Epithelial Tumors.
Cancer Vaccines: Preclinical Studies and Novel Strategies.
Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future.
Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines.
NK Cell Receptors as Tools in Cancer Immunotherapy.
Innate Immune Recognition and Suppression of Tumors.
Inhibitors of the HSP90 Molecular Chaperone: Current Status.

Cyber Week Pre-Sale | Use Code CYBOOK15

Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy

Contact Us